A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
Clinical trial NCT05276063 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05276063
- Sponsor
- Sling Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-01
- Primary completion
- 2024-10-15
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.